Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Fojtík

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Vnitrni Lekarstvi|March 11, 2006
[Anticoagulative therapy and antiphospholipid syndrome]Z Fojtík
Vnitrni Lekarstvi|September 14, 2006
[Antiphospholipid syndrome]Z Fojtík
Vnitrni Lekarstvi|June 25, 2004
[The significance of antiphospholipid antibodies]Z Fojtík
Vnitrni Lekarstvi|April 1, 1997
[Bisphosphonates, their mechanism of action and properties useful in the therapy of metabolic bone diseases]Z Fojtík, M Kandusová
Vnitrni Lekarstvi|May 28, 1998
[Bisphosphonates in the treatment of osteoporosis]Z Fojtík, M Kandusová
Vnitrni Lekarstvi|December 1, 1995
[Osteoporosis. 2]Z Fojtík, J Mayer
Vnitrni Lekarstvi|November 1, 1995
[Osteoporosis. 1]Z Fojtík, J Mayer
Ceska a Slovenska Oftalmologie : Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti|December 8, 2007
[Dry eye syndrome in rheumatoid arthritis patients]V Polanská, Z Hlinomazová, Z Fojtík, et al.
Ceska a Slovenska Oftalmologie : Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti|April 19, 2008
[The presence of dry eye syndrome and corneal complications in patients with rheumatoid arthritis and its association with -174 gene polymorphism for interleukin 6]V Polanská, O Serý, Z Fojtík, et al.
Vnitrni Lekarstvi|June 25, 2004
[Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus]Z Fojtík, M Beránek, M Klabusay, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Vnitrni Lekarstvi|March 11, 2006
[Anticoagulative therapy and antiphospholipid syndrome]Z Fojtík
Vnitrni Lekarstvi|September 14, 2006
[Antiphospholipid syndrome]Z Fojtík
Vnitrni Lekarstvi|June 25, 2004
[The significance of antiphospholipid antibodies]Z Fojtík
Vnitrni Lekarstvi|April 1, 1997
[Bisphosphonates, their mechanism of action and properties useful in the therapy of metabolic bone diseases]Z Fojtík, M Kandusová
Vnitrni Lekarstvi|May 28, 1998
[Bisphosphonates in the treatment of osteoporosis]Z Fojtík, M Kandusová
Vnitrni Lekarstvi|December 1, 1995
[Osteoporosis. 2]Z Fojtík, J Mayer
Vnitrni Lekarstvi|November 1, 1995
[Osteoporosis. 1]Z Fojtík, J Mayer
Ceska a Slovenska Oftalmologie : Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti|December 8, 2007
[Dry eye syndrome in rheumatoid arthritis patients]V Polanská, Z Hlinomazová, Z Fojtík, et al.
Ceska a Slovenska Oftalmologie : Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti|April 19, 2008
[The presence of dry eye syndrome and corneal complications in patients with rheumatoid arthritis and its association with -174 gene polymorphism for interleukin 6]V Polanská, O Serý, Z Fojtík, et al.
Vnitrni Lekarstvi|June 25, 2004
[Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus]Z Fojtík, M Beránek, M Klabusay, et al.
Pageof 2